IndiaTickerLatest filing: Oxygenta Pharmaceutical Ltd - 524636 - Announcement under Regulation 30 (LODR)-Change in Management
ObservedCompany dossier
Oxygenta Pharmaceutical
BSE:OXYGENTAPH · ISIN INE102E01018
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Oxygenta Pharmaceutical
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest ownership: promoter group 56.54% and public 43.46% as of 30 Jun 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing Oxygenta Pharmaceutical Ltd - 524636 - Announcement under Regulation 30 (LODR)-Change in Management
BSE · exchange filing
Observed
Source filing Oxygenta Pharmaceutical Ltd - 524636 - Un-Audited Results For The Quarter Ended 30.06.2026.
BSE · financial results
Observed
Source filing Oxygenta Pharmaceutical Ltd - 524636 - Board Meeting Outcome for Outcome For The Board Meeting Held On 27.07.2026
BSE · financial results
Observed
Source filing Oxygenta Pharmaceutical Ltd - 524636 - Update on board meeting
BSE · exchange filing
Reported financials
Full financials →Awaiting structured filing
No reconciled records in this module yet
Structured financial facts have not been reconciled.
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 56.54%
- Public
- 43.46%
- Employee trust
- N/A
Observed BSE shareholding XBRL